Shunmei: Integrated Coronary Catheter Innovation with Drug-Eluting Stent Technology
At Shunmei, our mission—Bring Patients Back to Health—guides every product we design. With 16 years of experience in the development and manufacturing of interventional medical devices, we offer a complete cardiovascular solution built on trust, science, and performance. Our coronary catheters are engineered to support complex interventions, and they work seamlessly with our proprietary drug-eluting stents to provide comprehensive treatment for ischemic heart disease.
Precision-Engineered Coronary Catheters for Clinical Control
Shunmei’s coronary catheter systems are designed for high navigability and precise delivery in challenging vascular anatomy. Physicians rely on our devices to access stenotic coronary vessels with control and confidence. Whether used for diagnostic angiography or stent deployment, each coronary catheter is optimized for pushability, torque control, and radiopaque visibility.
Our engineers work closely with interventional cardiologists to ensure our coronary catheters match the requirements of today’s advanced procedures. These catheters are not just conduits—they are clinical tools that provide responsive handling throughout every step of coronary access and therapy.
Drug-Eluting Stents Designed to Complement Catheter-Based Therapy
In addition to our coronary catheters, Shunmei offers a line of high-performance coronary drug-eluting stents. Manufactured from Co-Cr alloy and coated with a degradable sirolimus composite, our stents demonstrate sustained drug release for more than 90 days in preclinical studies. This extended release helps suppress restenosis and improves long-term vessel patency.
These stents are indicated for relieving vascular stenosis in patients with ischemic heart disease and are available in full-size configurations ranging from 2.0 mm to 5.0 mm in diameter and 8 mm to 48 mm in length. When paired with our coronary catheter systems, they provide a complete and integrated solution for coronary intervention.
End-to-End Manufacturing and Global Delivery Capability
With state-of-the-art production sites in Huizhou, Hunan, and Turkey, and subsidiaries covering major international markets, Shunmei supports healthcare providers in over 120 countries. Every coronary catheter and stent we produce adheres to ISO 13485 and ISO 10993 standards, ensuring full regulatory compliance and biocompatibility.
Shunmei’s fast-response logistics network enables timely shipment of both coronary catheters and stents, providing reliable access to life-saving devices during urgent procedures or routine interventions.
Conclusion
As we continue to innovate in cardiovascular technology, Shunmei remains committed to delivering advanced coronary catheters and stents that improve outcomes and empower clinical performance. Our integrated approach to product development enables healthcare teams to perform with greater confidence, precision, and efficiency.
With a vision to become a world-class medical equipment manufacturer of intervention, Shunmei stands at the forefront of modern cardiology—delivering trusted tools that create better futures for patients worldwide.
